Ares_M

    • Ares_MAres_M
      ·05-08
      7Comment
      Report
    • Ares_MAres_M
      ·05-08
      240Comment
      Report
    • Ares_MAres_M
      ·05-08
      $Etsy(ETSY)$  taking advantage of the post-earnings debacle bounce
      7Comment
      Report
    • Ares_MAres_M
      ·2023-04-28
      Well perhaps if they hadn´t pushed expats out and increased stamp duties to 60% among other things, Singapore would remain attractive as a place to place your money.
      Sorry, this post has been deleted
      2605
      Report
    • Ares_MAres_M
      ·2022-11-24
      I don´t see Meta going anywhere, if the metaverse evolves to something similar as seen in Ready Player Number One it will be through Google, Microsoft or Sony. On the other hand Snap approach as a VR makes much more sense but still I wouldn´t bet on them to be the most profitable for extensive VR applications/impementations
      Sorry, this post has been deleted
      42418
      Report
    • Ares_MAres_M
      ·2021-09-09
      $Invitae(NVTA)$¿End of Invitae's uptrend for now?
      187Comment
      Report
    • Ares_MAres_M
      ·2021-09-09
      $Sphere 3D(ANY)$playing safe
      214Comment
      Report
    • Ares_MAres_M
      ·2021-07-10
      $Digital Brands Group, Inc.(DBGI)$diamond hands here, this company is gonna keep growing through Amazon. Holding it till 2022 and maybe beyond!
      251Comment
      Report
    • Ares_MAres_M
      ·2021-06-12
      Great frist results from $CRISPR Therapeutics AG(CRSP)$& $Vertex(VTNR)$study on gen editing therapy to cure Thalssemia.CRSP is a clear win for 5y+ investors and has a massive growth ahead for the next 10 years, as a Biologist I can't but agree on the 9X figures.“This approach uses CRISPR/Cas9 gene editing to enable the patient’s own cells to produce fetal hemoglobin, and to see results that demonstrate the potential for a treatment that may transform the lives of many patients is an exciting time for me and the team.”https://www.businesswire.com/news/home/20210611005069/en/Vertex-and-CRISPR-Therapeutics-Present-New-Data-in-22-Patients-With-Greater-Than-3-Months-Follow-Up-Post-Treatment-With-Invest
      709Comment
      Report
    • Ares_MAres_M
      ·2021-06-10
      $Aethlon Medical(AEMD)$amazing pre-market trading session but the results of the clinical test sparking this boost makes AEMD like a solid company to invest on the long run
      845Comment
      Report
     
     
     
     

    Most Discussed

     
     
     
     
     

    Company: TTMF Limited. Tech supported by Xiangshang Yixin.

    Email:uservice@ttm.financial